PAVmed Inc. (NASDAQ:PAVM – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.67 and traded as high as $0.80. PAVmed shares last traded at $0.79, with a volume of 537,019 shares trading hands.
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets cut their target price on shares of PAVmed from $21.00 to $19.00 and set a “buy” rating on the stock in a research report on Monday, December 9th.
Check Out Our Latest Stock Analysis on PAVM
PAVmed Stock Performance
About PAVmed
PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.
Further Reading
- Five stocks we like better than PAVmed
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- What Are Dividend Champions? How to Invest in the Champions
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- How to trade using analyst ratings
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.
